PDCD1 and neoplasm: The Met@Man-MPs-reset macrophages not only directly killed and phagocytosed tumor cells to inhibit tumor growth, but also probably generated tumor antigen to increase the tumor recognition capability of cytotoxic T cells, potentiating anti-PD-1 treatment efficacy.